Thrombotic microangiopathy in patients with acquired immunodeficiency syndrome before and during the era of introduction of highly active antiretroviral therapy

Clinical Infectious Diseases

Volumn 35, Issue 12, 2002, Pages 1534-1540

  Gervasoni, Cristina ^a   Ridolfo, Anna Lisa ^a   Vaccarezza, Mauro ^a   Parravicini, Carlo ^a   Vago, Luca ^a   Adorni, Fulvio ^b   Cappelletti, Anna ^a   D'Arminio Monforte, Antonella ^a   Galli, Massimo ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b CNR   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTINEOPLASTIC AGENT; ANTIRETROVIRUS AGENT; BLEOMYCIN; CD4 ANTIGEN; HEPARIN; IMMUNOGLOBULIN; METHYLPREDNISOLONE; MITOMYCIN; VINCRISTINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADOLESCENT; ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CRYPTOSPORIDIOSIS; FEMALE; FOLLOW UP; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LEUKOCYTE COUNT; LUNG FIBROSIS; MAJOR CLINICAL STUDY; MALE; OPPORTUNISTIC INFECTION; PRIORITY JOURNAL; RISK ASSESSMENT; SCLERODERMA; THROMBOTIC THROMBOCYTOPENIC PURPURA; VIRUS INFECTION;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADOLESCENT; ADULT; AGED; ANTI-HIV AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; COHORT STUDIES; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PERIPHERAL VASCULAR DISEASES; RETROSPECTIVE STUDIES; RISK FACTORS; THROMBOSIS;

EID: 0037115151     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/344778     Document Type: Article

References (49)

1. Remuzzi G, Ruggenenti P. The hemolytic uremic syndrome. Kidney Int 1995; 48:2-19.
2. Neild GH. Haemolytic-uraemic syndrome in practice. Lancet 1994; 343:398-401.
3. Moake JL. Haemolytic-uraemic syndrome: Basic science. Lancet 1994; 343:393-7.
4. Sutor GC, Schmidt RE, Albrecht H. Thrombotic microangiopathies and HIV infection: Report of two typical cases, features of HUS and TTP, and review of the literature. Infection 1999; 27:12-5.
5. Del Arco A, Martinez MA, Pena JM, et al. Thrombotic thrombocytopenic purpura associated with human immunodeficiency virus infection: Demonstration of p24 antigen in endothelial cells. Clin Infect Dis 1993; 17:360-3.
6. Bachmeyer C, Blanche P, Sereni D, et al. Thrombotic thrombocytopenic purpura and haemolytic uraemic syndrome in HIV-infected patients. AIDS 1995; 9:532-3.
7. Kado DM, Korotzer BS, Brass EP. Clinical characterization of thrombotic microangiopathy in HIV infection. AIDS 1996; 10:1747-9.
8. Maslo C, Peraldi MN, Desenclos JC, et al. Thrombotic microangiopathy and cytomegalovirus disease in patients infected with human immunodeficiency virus. Clin Infect Dis 1997; 24:350-5.
9. Badesha PS, Saklayen MG. Hemolytic uremic syndrome as a presenting form of HIV infection. Nephron 1996; 72:472-5.
10. Leaf AN, Laubenstein LJ, Raphael B, Hochster H, Baez L, Karpatkin S. Thrombotic thrombocytopenic purpura associated with human immunodeficiency virus type 1 (HIV-1) infection. Ann Intern Med 1988; 109:194-7.
11. Sacristan Lista F, Saavedra Alonso AJ, Oliver Morales J, Vazquez Martul E. Nephrotic syndrome due to thrombotic microangiopathy (TMA) as the first manifestation of human immunodeficiency virus infection: Recovery before antiretroviral therapy without specific treatment against TMA. Clin Nephrol 2001; 55:404-7.
12. + T-cell determinations in persons infected with human immunodeficiency virus (HIV). MMWR Morb Mortal Wkly Rep 1997; 46:1-29
13. Centers for Disease Control and Prevention. 1993 Revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR Morb Mortal Wkly Rep 1992; 41(RR-17): 19-23. Available at http://www.cdc.gov/mmwr/preview/mmwrhtml/00018871.htm.
14. Dupon M, Marimoutou C, Cazorla C, et al. Incidence of acquired immunodeficiency syndrome (AIDS)-related Kaposi's sarcoma in the Aquitaine Cohort, France, 1988-1996. Groupe d'Epidemiologie Clinique du SIDA en Aquitaine. Int J Epidemiol 1998;27:1078-82.
15. Pedersen C, Danner S, Lazzarin A, et al. Epidemiology of cryptosporidiosis among European AIDS patients. Genitourin Med 1996;72: 128-31.
16. Gaber LW, Spargo BH, Lindheimer MD. Renal pathology in preeclampsia. Baillieres Clin Obstet Gynecol 1987; 1:971-5.
17. Byrnes J. Thrombotic thrombocytopenic purpura. Adv Intern Med 1980; 26:131-57.
18. Kovacs MJ, Roddy J, Gregoire S, Cameron W, Eidus L, Drouin J. Thrombotic thrombocytopenic purpura following hemorrhagic colitis due to Escherichia coli O157:H7. Am J Med 1990; 88:177-9.
19. Kwaan HC. Miscellaneous secondary thrombotic microangiopathy. Semin Hematol 1987; 24:141-7.
20. Brunner HI, Freedman M, Silverman ED. Close relationship between systemic lupus erythematosus and thrombotic thrombocytopenic purpura in childhood. Arthritis Rheum 1999;42:2346-55.
21. Jackson AM, Rose BD, Graff LG, et al. Thrombotic microangiopathy and renal failure associated with antineoplastic chemotherapy. Ann Intern Med 1984; 101:41-4.
22. Lhotta K, Kuhr T, Rumpelt HJ, Woll E, Thaler J, Konig P. Thrombotic microangiopathy with renal failure in two patients undergoing gemcitabine chemotherapy. Am J Nephrol 1999; 19:590-3.
23. Schulz A, Sitzler G, Scheid C, et al. A case of thrombotic thrombocytopenic purpura in an adult treated with vincristine. Ann Hematol 1999; 78:39-42.
24. Lohrmann H-P, Adam W, Heymer B, Kubanek B. Microangiopathic hemolytic anemia in metastatic carcinoma: Report of eight cases. Ann Intern Med 1973; 79:368-75.
25. Moody H, Matz L, Hurst P. Vascular lesions as manifestation of cyclosporin nephrotoxicity. Lancet 1986; 1:1221-2.
26. Laffay DL, Tubbs RR, Valenzuela MD, Hall PM, McCormack LJ. Chronic glomerular microangiopathy and metastatic carcinoma. Hum Pathol 1979; 10:433-8.
27. Bennett CL, Davidson CJ, Raisch DW, Weinberg PD, Bennett RH, Feldman MD. Thrombotic thrombocytopenic purpura associated with ticlopidine in the setting of coronary artery stents and stroke prevention. Arch Intern Med 1999; 159:2524-8.
28. Bennett CL, Connors JM, Carwile JM, et al. Thrombotic thrombocytopenic purpura associated with clopidogrel. N Engl J Med 2000; 342:1773-7.
29. Tumlin JA, Sands JM, Someren A. A hemolytic-uremic syndrome following "crack" cocaine inhalation. Am J Med Sci 1990;299:366-71.
30. Volcy J, Nzerue CM, Oderinde A, Hewan-Iowe K. Cocaine-induced acute renal failure, hemolysis, and thrombocytopenia mimicking thrombotic thrombocytopenic purpura. Am J Kidney Dis 2000; 35:E3.
31. d'Arminio Monforte A, Mainini F, Testa L, et al. Predictors of cytomegalovirus disease, natural history and autopsy findings in a cohort of patients with AIDS. AIDS 1997; 11:517-24.
32. Kressel BR, Ryan KP, Duong AT, Berenberg J, Schein PS. Microangiopathic hemolytic anemia, thrombocytopenia, and renal failure in patients treated for adenocarcinoma. Cancer 1981;48:1738-45.
33. Cohen IS, Mosher MB, O'Keefe EJ, Klaus SN, De Conti RC. Cutaneous toxicity of bleomycin therapy. Arch Dermatol 1973; 107:553-5.
34. Yagoda A, Mukherji B, Young C, et al. Bleomycin, an antitumor antibiotic: Clinical experience in 274 patients. Ann Intern Med 1972; 77: 861-70.
35. Vogelzang NJ, Bosl GJ, Johnson K, Kennedy BY. Raynaud's phenomenon: A common toxicity after combination chemotherapy for testicular cancer. Ann Intern Med 1981; 95:288-92.
36. Hall S, Glickman M. The British paediatric surveillance unit. Arch Dis Child 1988; 63:344-6.
37. Bottieau E, Colebunders R, Bosmans JL. Favourable outcome of haemolytic uraemic syndrome in an HIV-infected patient treated only with prednisone. J Infect 2000;41:108-9.
38. Gruszecki AC, Wehrli G, Ragland BD, et al. Management of a patient with HIV infection-induced anemia and thrombocytopenia who presented with thrombotic thrombocytopenic purpura. Am J Hematol 2002; 69:228-31.
39. Sacristan Lista F, Saavedra Alonso AJ, Oliver Morales J, Vazquez Martul E. Nephrotic syndrome due to thrombotic microangiopathy (TMA) as the first manifestation of human immunodeficiency virus infection: Recovery before antiretroviral therapy without specific treatment against TMA. Clin Nephrol 2001; 55:404-7.
40. Dupont C, Vasseur E, Beauchet A, et al. Long-term efficacy on Kaposi's sarcoma of highly active antiretroviral therapy in a cohort of HIV-positive patients. CISIH 92. Centre d'Information et de Soins de l'Immunodeficience Humaine. AIDS 2000; 14:987-93.
41. Thompson CE, Damon LE, Ries CA, Linker CA. Thrombotic microangiopathies in the 1980s: Clinical features, response to treatment, and the impact of the human immunodeficiency virus epidemic. Blood 1992; 80:1890-5.
42. Bell WR, Braine HG, Ness PM, Kickler TS. Improved survival in thrombotic thrombocytopenic purpura-hemolytic uremic syndrome. N Engl J Med 1991;325:398-403.
43. George JN. How I treat patients with thromhotic thrombocytopenic purpura-hemolytic uremic syndrome. Blood 2000; 96:1223-9.
44. Kell WJ, Dasani H, Collins PW. Aggressive treatment of HIV-associated microangiopathic haemolytic anaemia is associated with good outcome. Am J Nephrol 1998; 18:260.
45. Kelleher P, Severn A, Tomson C, et al. The haemolytic uraemic syndrome in patients with AIDS. Genitourin Med 1996; 72:172-5.
46. Ucar A, Fernandez HF, Byrnes JJ, Lian EC, Harrington WJ Jr. Thrombotic microangiopathy and retroviral infections: A 13-year experience. Am J Hematol 1994;45:304-9.
47. Beattie TJ, Murphy AV, Willoughby MCN, Machin SS, Defrein G. Plasmapheresis in the haemolytic uraemic syndrome in children. Br Med J (Clin Res Ed) 1981;282:1667-8.
48. Lara PN Jr, Coe TL, Zhou H, Fernando L, Holland PV, Wun T. Improved survival with plasma exchange in patients with thrombotic thrombocytopenic purpura hemolytic uremic syndrome. Am J Med 1999; 107:573-9.
49. Rizzoni G, Claris-Appiani A, Edefonti A, et al. Plasma infusion for hemolytic-uremic syndrome in children: Results of a multicenter controlled trial. J Pediatr 1988; 112:284-90.